Dihydroartemisinin-Piperaquine or Sulphadoxine-Pyrimethamine for the Chemoprevention of Malaria in Sickle Cell Anaemia
Clinical trial NCT04844099 · COMPLETED
Trial details
- NCT number
- NCT04844099
- Sponsor
- Liverpool School of Tropical Medicine
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-09
- Primary completion
- 2023-06-30
- Enrollment
- 723
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.